Your browser doesn't support javascript.
loading
VIBRANT: spectral profiling for single-cell drug responses.
Liu, Xinwen; Shi, Lixue; Zhao, Zhilun; Shu, Jian; Min, Wei.
Afiliação
  • Liu X; Department of Chemistry, Columbia University, New York, NY, USA.
  • Shi L; Department of Chemistry, Columbia University, New York, NY, USA.
  • Zhao Z; Shanghai Xuhui Central Hospital, Zhongshan-Xuhui Hospital, and Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai, China.
  • Shu J; Department of Chemistry, Columbia University, New York, NY, USA.
  • Min W; Cutaneous Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Nat Methods ; 21(3): 501-511, 2024 Mar.
Article em En | MEDLINE | ID: mdl-38374266
ABSTRACT
High-content cell profiling has proven invaluable for single-cell phenotyping in response to chemical perturbations. However, methods with improved throughput, information content and affordability are still needed. We present a new high-content spectral profiling method named vibrational painting (VIBRANT), integrating mid-infrared vibrational imaging, multiplexed vibrational probes and an optimized data analysis pipeline for measuring single-cell drug responses. Three infrared-active vibrational probes were designed to measure distinct essential metabolic activities in human cancer cells. More than 20,000 single-cell drug responses were collected, corresponding to 23 drug treatments. The resulting spectral profile is highly sensitive to phenotypic changes under drug perturbation. Using this property, we built a machine learning classifier to accurately predict drug mechanism of action at single-cell level with minimal batch effects. We further designed an algorithm to discover drug candidates with new mechanisms of action and evaluate drug combinations. Overall, VIBRANT has demonstrated great potential across multiple areas of phenotypic screening.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article